Trial Profile
Effects of Repeated 3-month Administration of Miglitol and Voglibose on Vascular Endothelial Function in Type 2 Diabetic Patients with Coronary Heart Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Miglitol (Primary) ; Voglibose
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 14 Nov 2011 New trial record